Tag Archives: CBI

Chicago Bridge Gets a Hold Rating from Robert W. Baird

In a report released yesterday, Andrew Wittmann from Robert W. Baird reiterated a Hold rating on Chicago Bridge (NYSE: CBI), with a price target of $14. The company’s shares closed yesterday at $13.38. According to TipRanks.com, Wittmann is a 3-star

Robert W. Baird Sticks to Its Hold Rating for Chicago Bridge

In a report released today, Andrew Wittmann from Robert W. Baird reiterated a Hold rating on Chicago Bridge (NYSE: CBI), with a price target of $16. The company’s shares opened today at $12.44, close to its 52-week low of $9.55.

Wednesday’s Midday Stock Update: Conatus Pharmaceuticals (CNAT), Biocept Inc (BIOC), Chicago Bridge (CBI), Inovio Pharmaceuticals (INO), Himax Technologies (HIMX)

So far Wednesday, January 24, NASDAQ is down -2.75% and the S&P is down -0.92%. Here are this morning’s most active stocks: Conatus Pharmaceuticals (NASDAQ:CNAT), Biocept Inc (NASDAQ:BIOC), Chicago Bridge (NYSE:CBI), Inovio Pharmaceuticals (NASDAQ:INO) and Himax Technologies (NASDAQ:HIMX). Conatus Pharmaceuticals

Robert W. Baird Reiterates a Hold Rating on Chicago Bridge

Robert W. Baird analyst Andrew Wittmann reiterated a Hold rating on Chicago Bridge (NYSE: CBI) today and set a price target of $17. The company’s shares opened today at $16.73. According to TipRanks.com, Wittmann is a 4-star analyst with an

Chicago Bridge Receives a Hold from Robert W. Baird

In a report issued on October 20, Andrew Wittmann from Robert W. Baird reiterated a Hold rating on Chicago Bridge (NYSE: CBI), with a price target of $10. The company’s shares closed on Friday at $16. According to TipRanks.com, Wittmann

KeyBanc Sticks to Its Hold Rating for Chicago Bridge

In a report issued on September 19, Tahira Afzal from KeyBanc reiterated a Hold rating on Chicago Bridge (NYSE: CBI). The company’s shares closed yesterday at $16.26. According to TipRanks.com, Afzal is a 4-star analyst with an average return of